Shares of Eli Lilly and Co (LLY) closed at $1,179.27 on October 9, 2026, gaining $1.25 or 0.83%. This uptick came during an all-around favorable trading session for the stock market, with the S&P 500 advancing 0.60% and the Dow Jones Industrial Average rising 0.87%.
During the session, LLY saw intraday trading range between $1,161.58 and $1,196.96, with a total trading volume of 2.20 million shares. The closing price remains 8.8% below its 52-week high of $1,292.65, while also being significantly above its 52-week low of $783.85, indicating that while the stock has room to recover, it is still consolidating below its previous peaks.
In terms of competitive performance, Eli Lilly underperformed slightly against its sector peers, with SPY moving up 0.60% to $778.57 and QQQ increasing 0.49% to $751.27. While LLY’s gains were modest, the broader market and its competitors showed stronger momentum.